Cancer, Advanced Completed Phase 1 Trials for Bortezomib (DB00188)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00770731Study of Temsirolimus, Topotecan, and BortezomibTreatment
NCT00895687Study of Erlotinib in Combination With BortezomibTreatment